tirzepatide type 1 diabetes trial in Adults With Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical @DiabetesCareADA 🔻 −10.3 kg in 12 weeks with tirzepatide vs −0.7 kg with placebo (P<0.0001) 🎯 100% ≥5% Read now: The SURPASS-EARLY trial

Recurrent massive hemorrhage from benign hepatic tumors secondary to oral contraceptives

Jacobs, and J

The Risks of Compounded GLP-1 Drugs Many clinicians are happy to prescribe compounded GLP-1 weight loss drugs, but some experts caution that the limited oversight may expose patients to unnecessary risks

Tirzepatide is a groundbreaking injectable medication that targets both GLP-1 and GIP receptors, helping to regulate appetite, improve blood sugar levels, and promote sustainable weight loss

These compounds are thought to interact with cellular receptors involved in tissue recovery, potentially supporting collagen synthesis and dermal hydration

Glutathione (GSH), composed of gamma-glutamylcysteinylglycine, stands as the most abundant intracellular thiol in aerobic cells, and its synthesis by GSS is essential for diverse cellular processes